Antimicrobial mechanism of lantibiotics

Biochemical Society Transactions

Volumn 40, Issue 6, 2012, Pages 1528-1533

  Islam, Mohammad R ^a   Nagao, Jun Ichi ^b   Zendo, Takeshi ^a   Sonomoto, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Bacteriocin; Cell wall inhibition; Lantibiotic; Lipid II; Pore forming peptide

Indexed keywords

LACTICIN 3147; LANTIBIOTIC; MERSACIDIN; NISIN; NUKASIN ISK 1; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BIOSYNTHESIS; CELL WALL; CONFERENCE PAPER; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACTERIOCINS; CELL MEMBRANE PERMEABILITY; CELL WALL; GRAM-POSITIVE BACTERIA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDOGLYCAN; PROTEIN BINDING; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

EID: 84870180442     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120190     Document Type: Conference Paper

References (44)

1. de Vuyst, L. and Vandamme, E.J. (1994) Bacteriocins of Lactic Acid Bacteria: Microbiology, Genetics and Applications. Blackie Academic and Professional, London
2. Jung, G. and Sahl, H.-G. (1991) Lantibiotics: a survey. In Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., eds), pp. 1-34, Escom, Leiden
3. Willey, J.M. and van der Donk, W.A. (2007) Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501 (Pubitemid 350058218)
4. Brumfitt, W., Salton, M.R. and Hamilton-Miller, J.M. (2002) Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50, 731-734 (Pubitemid 35331693)
5. Gross, E. and Morell, J.L. (1971) The structure of nisin. J. Am. Chem. Soc. 93, 4634-4635
6. Benz, R., Jung, G. and Sahl, H.-G. (1991) Mechanism of channel formation by lantibiotics in black lipid membranes. In Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., eds), pp. 359-372, Escom, Leiden
7. Sahl, H.-G. (1991) Pore formation in bacterial membranes by cationic lantibiotics. In Nisin and Novel Lantibiotics (Jung, G. and Sahl, H.-G., eds), pp. 347-358, Escom, Leiden
8. Breukink, E. and de Kruijff, B (1999) The lantibiotic nisin, a special case or not? Biochim. Biophys. Acta 1462, 223-234
9. Driessen, A.J., van den Hooven, H.W., Kuiper, W., van de Kamp, M., Sahl, H.-G., Konings, R.N. and Konings, W.N. (1995) Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. Biochemistry 34, 1606-1614
10. Giffard, C.J., Ladha, S., Mackie, A.R., Clark, D.C. and Sanders, D. (1996) Interaction of nisin with planar lipid bilayers monitored by fluorescence recovery after photobleaching. J. Membr. Biol. 151, 293-300 (Pubitemid 26225009)
11. Martin, I., Ruysschaert, J.M., Sanders, D. and Giffard, C.J. (1996) Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan. Eur. J. Biochem. 239, 156-164 (Pubitemid 26228154)
12. Breukink, E., Ganz, P., de Kruijff, B. and Seelig, J. (2000) Binding of Nisin Z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry 39, 10247-10254 (Pubitemid 30663047)
13. Giffard, C.J., Dodd, H.M., Horn, N., Ladha, S., Mackie, A.R., Parr, A., Gasson, M.J. and Sanders, D. (1997) Structure-function relations of variant and fragment nisins studied with model membrane systems. Biochemistry 36, 3802-3810 (Pubitemid 27154700)
14. Breukink, E., van Kraaij, C., Demel, R.A., Siezen, R.J., Kuipers, O.P. and de Kruijff, B. (1997) The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36, 6968-6976 (Pubitemid 27258109)
15. Moll, G.N., Clark, J., Chan, W.C., Bycroft, B.W., Roberts, G.C., Konings, W.N. and Driessen, A.J. (1997) Role of transmembrane pH gradient and membrane binding in nisin pore formation. J. Bacteriol. 179, 135-140 (Pubitemid 26428475)
16. Lins, L., Ducarme, P., Breukink, E. and Brasseur, R. (1999) Computational study of nisin interaction with model membrane. Biochim. Biophys. Acta 1420, 111-120 (Pubitemid 29369024)
17. van Kraaij, C., Breukink, E., Noordermeer, M.A., Demel, R.A., Siezen, R.J., Kuipers, O.P. and de Kruijff, B. (1998) Pore formation by nisin involves translocation of its C-terminal part across the membrane. Biochemistry 37, 16033-16040 (Pubitemid 28536240)
18. Demel, R.A., Peelen, T., Siezen, R.J., De Kruijff, B. and Kuipers, O.P. (1996) Nisin Z, mutant nisin Z and lacticin 481 interactions with anionic lipids correlate with antimicrobial activity: a monolayer study. Eur. J. Biochem. 235, 267-274
19. Garcerá, M.J., Elferink, M.G., Driessen, A.J. and Konings, W.N. (1993) In vitro pore-forming activity of the lantibiotic nisin: role of protonmotive force and lipid composition. Eur. J. Biochem. 212, 417-422 (Pubitemid 23076109)
20. Breukink, E., van Kraaij, C., van Dalen, A., Demel, R.A., Siezen, R.J., de Kruijff, B. and Kuipers, O.P. (1998) The orientation of nisin in membranes. Biochemistry 37, 8153-8162 (Pubitemid 28307078)
21. McAuliffe, O., Ross, R.P. and Hill, C. (2001) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol. Rev. 25, 285-308 (Pubitemid 32429585)
22. Breukink, E., van Heusden, H.E., Vollmerhaus, P.J., Swiezewska, E., Brunner, L., Walker, S., Heck, A.J. and de Kruijff, B. (2003) Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J. Biol. Chem. 278, 19898-19903 (Pubitemid 36799179)
23. Brötz, H., Josten, M., Wiedemann, I., Schneider, U., Götz, F., Bierbaum, G. and Sahl, H.-G. (1998) Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30, 317-327 (Pubitemid 28480183)
24. Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O.P., Sahl, H.-G. and de Kruijff, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361-2364 (Pubitemid 30016902)
25. van Heusden, H.E., de Kruijff, B. and Breukink, E. (2002) Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin. Biochemistry 41, 12171-12178
26. Wiedemann, I., Benz, R. and Sahl, H.-G. (2004) Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J. Bacteriol. 186, 3259-3261 (Pubitemid 38609772)
27. Hsu, S.T., Breukink, E., Tischenko, E., Lutters, M.A., de Kruijff, B., Kaptein, R., Bonvin, A.M. and van Nuland, N.A. (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11, 963-967 (Pubitemid 39315300)
28. Martin, N.I. and Breukink, E. (2007) Expanding role of lipid II as a target for lantibiotics. Future Microbiol. 2, 513-525 (Pubitemid 47578215)
29. Willey, J.M. and van der Donk, W.A. (2007) Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61, 477-501 (Pubitemid 350058218)
30. Hasper, H.E., Kramer, N.E., Smith, J.L., Hillman, J.D., Zachariah, C., Kuipers, O.P., de Kruijff, B. and Breukink, E. (2006) An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636-1637 (Pubitemid 44414037)
31. de Kruijff, B., van Dam, V. and Breukink, E. (2008) Lipid II: a central component in bacterial cell wall synthesis and a target for antibiotics. Prostaglandins Leukotrienes Essent. Fatty Acids 79, 117-121
32. Chatterjee, C., Paul, M., Xie, L. and van der Donk, W.A. (2005) Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633-684
33. Asaduzzaman, S.M., Nagao, J., Aso, Y., Nakayama, J. and Sonomoto, K. (2006) Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1. Appl. Environ. Microbiol. 72, 6012-6017 (Pubitemid 44414630)
34. Jack, R., Benz, R., Tagg, J. and Sahl, H.-G. (1994) The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 219, 699-705 (Pubitemid 24053689)
35. Asaduzzaman, S.M., Nagao, J., Iida, H., Zendo, T., Nakayama, J. and Sonomoto, K. (2009) Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob. Agents Chemother. 53, 3595-3598
36. Islam, M.R., Nishie, M., Nagao, J., Zendo, T., Keller, S., Nakayama, J., Kohda, D., Sahl, H.G. and Sonomoto, K. (2012) Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J. Am. Chem. Soc. 134, 3687-3690
37. Brötz, H., Bierbaum, G., Markus, A., Molitor, E. and Sahl, H.-G. (1995) Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob. Agents Chemother. 39, 714-719
38. Brötz, H., Bierbaum, G., Reynolds, P.E. and Sahl, H.-G. (1997) The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur. J. Biochem. 246, 193-199 (Pubitemid 27229687)
39. Brötz, H., Bierbaum, G., Leopold, K., Reynolds, P.E. and Sahl, H.-G. (1998) The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother. 42, 154-160 (Pubitemid 28053343)
40. Hsu, S.T., Breukink, E., Bierbaum, G., Sahl, H.-G., de Kruijff, B., Kaptein, R., van Nuland, N.A. and Bonvin, A.M. (2003) NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles: conformational changes are a key to antimicrobial activity. J. Biol. Chem. 278, 13110-13117 (Pubitemid 36800079)
41. Ryan, M.P., Rea, M.C., Hill, C. and Ross, R.P. (1996) An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl. Environ. Microbiol. 62, 612-619
42. Wiedemann, I., Böttiger, T., Bonelli, R.R., Wiese, A., Hagge, S.O., Gutsmann, T., Seydel, U., Deegan, L., Hill, C., Ross, P. and Sahl, H.-G. (2006) The mode of action of the lantibiotic lacticin 3147: a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61, 285-296 (Pubitemid 44356563)
43. Cotter, P.D., Deegan, L.H., Lawton, E.M., Draper, L.A., O'Connor, P.M., Hill, C. and Ross, R.P. (2006) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol. Microbiol. 62, 735-747 (Pubitemid 44571598)
44. Oman, T.J. and van der Donk, W.A. (2009) Insights into the mode of action of the two-peptide lantibiotic haloduracin. ACS Chem. Biol. 4, 865-874